Showing results (281-290 of 363) with videos related to

Sort By:
Pageof 37
British Journal of Clinical Pharmacology|October 1, 1993
The pharmacokinetics of tranylcypromine enantiomers in healthy subjects after oral administration of racemic drug and the single enantiomersH Weber-Grandke, G Hahn, E Mutschler, et al.
Arzneimittel-Forschung|January 1, 1985
Single-dose kinetics of oral propranolol, metoprolol, atenolol, and sotalol: relation to lipophilicityH R Ochs, D J Greenblatt, R M Arendt, et al.
Annals of Surgical Oncology|November 27, 1998
Primary leiomyosarcoma of bone: clinicopathologic, immunohistochemical, and molecular biologic aspectsR J Wirbel, S Verelst, R Hanselmann, et al.
European Journal of Clinical Pharmacology|June 24, 1999
Renal handling of drugs in the healthy elderly. Creatinine clearance underestimates renal function and pharmacokinetics remain virtually unchangedD Fliser, I Bischoff, A Hanses, et al.
Clinical Pharmacology and Therapeutics|August 1, 1993
Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administrationK Witte, K Weisser, M Neubeck, et al.
European Journal of Pharmacology|August 11, 1987
Binding of the S(+)- and R(-)-enantiomers of bethanechol to muscarinic receptors in jejunal smooth muscle, nasal mucosa, atrial and ventricular myocardium of the ratT Buhl, J F Rodrigues de Miranda, A J Beld, et al.
European Journal of Pharmacology|December 13, 1988
Presynaptic muscarinic receptors mediating inhibition of neurogenic contractions in rabbit vas deferens are of the ganglionic M1-typeM Eltz, G Gmelin, J Wess, et al.
Arzneimittel-Forschung|February 23, 2000
Muscarinic properties of compounds related to arecaidine propargyl esterV Tumiatti, J Wehrle, C Hildebrandt, et al.
Der Unfallchirurg|March 27, 2003
[Relevance of CT-scans for pediatric head injuries]B Maier, A Maier-Hemming, M Lehnert, et al.
European Journal of Pharmacology|November 24, 1995
The (S)-(+)-enantiomer of dimethindene: a novel M2-selective muscarinic receptor antagonistO Pfaff, C Hildebrandt, M Waelbroeck, et al.
Pageof 37